Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 意大利共识声明：促进炎症性肠病患者的心理社会健康

2021-11-28 国外精神科相关专家小组（统称） BMC Psychol

炎症性肠病心理社会健康

炎症性肠病（IBD）是与胃肠道有关的缓解和复发性疾病，IBD与一种心理-社会不适应状态相关，严重影响患者的生活质量。

中文标题：

2021 意大利共识声明：促进炎症性肠病患者的心理社会健康

英文标题：

Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement

发布机构：

国外精神科相关专家小组（统称）

发布日期：

2021-11-28

简要介绍：

炎症性肠病（IBD）是与胃肠道有关的缓解和复发性疾病，IBD与一种心理-社会不适应状态相关，严重影响患者的生活质量。本文建议对于IBD患者的心理社会需求进行早期检测，并在需要时进行干预，以实现患者参与疾病的护理。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 意大利共识声明：促进炎症性肠病患者的心理社会健康.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5e2521c0022e9aae, title=2021 意大利共识声明：促进炎症性肠病患者的心理社会健康, enTitle=Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement, guiderFrom=BMC Psychol, authorId=0, author=, summary=炎症性肠病（IBD）是与胃肠道有关的缓解和复发性疾病，IBD与一种心理-社会不适应状态相关，严重影响患者的生活质量。, cover=https://img.medsci.cn/20211130/1638250486880_5579292.png, journalId=0, articlesId=null, associationId=1320, associationName=国外精神科相关专家小组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Sun Nov 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">炎症性肠病（IBD）是与胃肠道有关的缓解和复发性疾病，IBD与一种心理-社会不适应状态相关，严重影响患者的生活质量。本文建议对于IBD患者的心理社会需求进行早期检测，并在需要时进行干预，以实现患者参与疾病的护理。</span></p>, tagList=[TagDto(tagId=1125, tagName=炎症性肠病), TagDto(tagId=118768, tagName=心理社会健康)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=13, categoryName=精神心理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1125, guiderKeyword=炎症性肠病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2632, appHits=113, showAppHits=0, pcHits=418, showPcHits=2518, likes=0, shares=9, comments=5, approvalStatus=1, publishedTime=Tue Nov 30 13:43:01 CST 2021, publishedTimeString=2021-11-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 30 13:39:03 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 21:19:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 意大利共识声明：促进炎症性肠病患者的心理社会健康.pdf)])
2021 意大利共识声明：促进炎症性肠病患者的心理社会健康.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1205856, encodeId=834f12058563b, content=附件无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 25 14:51:30 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082720, encodeId=d17e1082e2099, content=很重要的知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Tue Dec 21 21:53:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077023, encodeId=616a10e7023c5, content=谢谢谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:37 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075678, encodeId=470610e567847, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:17 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2022-03-25 ms5000001586473032

    附件无法下载

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1205856, encodeId=834f12058563b, content=附件无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 25 14:51:30 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082720, encodeId=d17e1082e2099, content=很重要的知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Tue Dec 21 21:53:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077023, encodeId=616a10e7023c5, content=谢谢谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:37 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075678, encodeId=470610e567847, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:17 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-21 freegut

    很重要的知识点

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1205856, encodeId=834f12058563b, content=附件无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 25 14:51:30 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082720, encodeId=d17e1082e2099, content=很重要的知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Tue Dec 21 21:53:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077023, encodeId=616a10e7023c5, content=谢谢谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:37 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075678, encodeId=470610e567847, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:17 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-05 微探

    谢谢谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1205856, encodeId=834f12058563b, content=附件无法下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbe75476304, createdName=ms5000001586473032, createdTime=Fri Mar 25 14:51:30 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082720, encodeId=d17e1082e2099, content=很重要的知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8c891547870, createdName=freegut, createdTime=Tue Dec 21 21:53:00 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077023, encodeId=616a10e7023c5, content=谢谢谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sun Dec 05 08:21:37 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075678, encodeId=470610e567847, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Dec 01 07:01:17 CST 2021, time=2021-12-01, status=1, ipAttribution=)]
    2021-12-01 微探

    学习学习

    0

相关指南

2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2021-08-01

2021 CAG临床实践指南：炎症性肠病患者免疫接种—第1部分：活疫苗

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2021-02-19

2021 WSES/AAST指南：炎症性肠病的急诊管理

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2021-05-11

2021 国际共识：炎症性肠病患者静脉和动脉血栓性事件的预防

国外消化科相关专家小组（统称） · 2021-08-27

关于炎症性肠病静脉血栓栓塞风险、预防和治疗的共识声明：加拿大胃肠病学协会

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2021-09-01

炎症性肠病患者静脉和动脉血栓事件预防国际共识

国际炎症性肠病研究组织(IOIBD,International Organization For the Study of Inflammatory Bowel Disease) · 2021-09-01

拓展阅读

2014年加拿大炎症性肠病（IBD）与静脉血栓防治共识意见：加拿大胃肠病学会

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-03-01

2014 ESPGHAN儿童和青少年炎症性肠病诊断的波尔图标准（修订版）

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2014-06-10

2014 CAG立场声明：应用巯嘌呤类药物治疗炎症性肠病

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-07-04

2015 ASGE指南：内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20

2016 建立我国炎症性肠病诊治中心质量控制指标的共识

中华医学会消化病学分会炎症性肠病学组 · 2016-07-30

2017 IG-IBD临床实践指南：应用糖皮质激素和免疫抑制药物治疗炎症性肠病

意大利炎症性肠病研究组(IG-IBD,Italian Group for the Study of Inflammatory Bowel Disease) · 2017-01-25

Baidu
map
Baidu
map
Baidu
map